NASDAQ : SNWV
SANUWAVE Health, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 5.27 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 45.33M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 44.30M |
| Enterprise Value | 55.63M |
Dates
| Measure | Value |
|---|
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 8.60M |
| Shares Outstanding | 8.60M |
| Shares Change (YoY) | +26.84% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 4.91% |
| Owned by Institutions (%) | 25.02% |
| Float | 6.19M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 6.59 |
| Forward PE | n/a |
| PS Ratio | 1.01 |
| Forward PS | 1.46 |
| PB Ratio | 15.90 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 10.53 |
| P/OCF Ratio | 8.48 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 3.65 |
| EV / Sales | 1.26 |
| EV / EBITDA | 13.05 |
| EV / EBIT | 18.13 |
| EV / FCF | 13.22 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.28 |
| Quick Ratio | 0.84 |
| Debt / Equity | 7.43 |
| Debt / EBITDA | 4.66 |
| Debt / FCF | 4.92 |
| Interest Coverage | 0.89 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 5.51% |
| Return on Invested Capital (ROIC) | 22.32% |
| Return on Capital Employed (ROCE) | 16.65% |
| Weighted Average Cost of Capital (WACC) | 13.50% |
| Revenue Per Employee | $800,400 |
| Profits Per Employee | $277,436 |
| Employee Count | 55 |
| Asset Turnover | 1.26 |
| Inventory Turnover | 1.61 |
Taxes
| Measure | Value |
|---|
| Income Tax | 92,000 |
| Effective Tax Rate | 0.60% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.42 |
| 52-Week Price Change | -83.08% |
| 50-Day Moving Average | 4.82 |
| 200-Day Moving Average | 13.49 |
| Relative Strength Index (RSI) | 50.36 |
| Average Volume (20 Days) | 42,307 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 236,233 |
| Short Previous Month | 245,504 |
| Short % of Shares Out | 2.75% |
| Short % of Float | 3.82% |
| Short Ratio (days to cover) | 3.99 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 44.02M |
| Gross Profit | 33.60M |
| Operating Income | 3.07M |
| Pretax Income | 15.35M |
| Net Income | 15.26M |
| EBITDA | 4.26M |
| EBIT | 3.07M |
| Earnings Per Share (EPS) | $0.78 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 9.38M |
| Total Debt | 20.71M |
| Net Cash | -11.33M |
| Net Cash Per Share | -$1.32 |
| Equity (Book Value) | 2.79M |
| Book Value Per Share | 0.32 |
| Working Capital | 5.03M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 5.22M |
| Capital Expenditures | -1.01M |
| Depreciation & Amortization | 1.19M |
| Net Borrowing | -8.50M |
| Free Cash Flow | 4.21M |
| FCF Per Share | $0.49 |
Margins
| Measure | Value |
|---|
| Gross Margin | 76.33% |
| Operating Margin | 6.97% |
| Pretax Margin | 34.87% |
| Profit Margin | 34.66% |
| EBITDA Margin | 9.68% |
| EBIT Margin | 6.97% |
| FCF Margin | 9.56% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -26.84% |
| Shareholder Yield | -26.84% |
| Earnings Yield | 15.18% |
| FCF Yield | 9.50% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 18, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:375 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -3.54 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |